Recently, it has been shown that inhibiting TGF-β can reduce fibrosis and improve regeneration in several genetic forms of myopathy, including dystrophin-negative Duchenne muscular dystrophy and Marfan syndrome [57,58,59]. This evidence concerns the gene TGFB1 and Duchenne muscular dystrophy.